Our Team.
Management
Filippa Shub, M.Sc, MBA, Patent and Trade Mark Attorney
COO
An accomplished healthcare industry exec with experience in Operations, IP and Clinical Trials Management, including CSL and Starpharma.
_edited_edited.jpg)
Richard Foitzik, PhD
Director of Medicinal Chemistry
With over 15 years commercial medicinal chemistry experience and an inventor on 15 patents, including IP licensed to Pfzier and Amplia and in clinical development.
Roy Kong, PhD
Principal Scientist
Roy has extensive experience in designing translational programs around preclinical fibrosis models and assays and progressing leads rapidly to the clinic. He was previously Research Director of Molecular Biology with both Certa and OccuRx.
Consultants
Dr Neil Miller
Medchem Consultant
Dr Alan Naylor
Medchem Consultant
Dr Alberto Buson
Pharmacology Consultant
Board Directors
Founders
David Philips
Executive Chair
Over 40 years pharmaceutical industry experience including Member of the Exec team at Galapagos, Senior marketing exec with GSK and Managing Partner of GSK’s Corporate Venture Fund.
Siro Perez, PhD, MFin
Director
Siro is Head of Life Sciences at IP Group Australia and has over 20 years of international experience across the whole R&D, commercialization, and investment process in life sciences.
Aiofe Cullen, PhD
Director
Aoife, head of Life Sciences Commercialization at Monash University, has had a diverse and international background in technology transfer, spinout creation and business development.
A. Prof. Siew Chai
Co Founder and IRAP expert
A Prof. Tracey Gaspari
Co-founder and IRAP pharmacology expert
Prof. Phil Thompson
Co-founder and
medicinal chemist
Prof. Rob Widdop
Co-founder and
IRAP physiology expert